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ABSTRACT
The signiﬁcance of Clostridium spp. in blood cultures was evaluated by two methods. In the ﬁrst part of
the study, a group of 80 patients with Clostridium spp. bacteraemia was compared with a group of 100
patients with Bacillus spp. in blood cultures, making the assumption that Bacillus almost invariably
represents contamination (pseudobacteraemia). Signiﬁcant differences were found between the two
groups, suggesting that growth of Clostridium did not represent pseudobacteraemia. Patients with
Clostridium bacteraemia were older, had a higher frequency of gastrointestinal disease (especially
colorectal tumours), were associated more frequently with polymicrobial bacteraemia, and had a higher
mortality rate. In the second part of the study, each of the 80 cases of Clostridium bacteraemia was
evaluated individually for clinical relevance by an infectious diseases expert. In two-thirds of the cases,
isolates of Clostridium from blood were considered to be of clinical relevance, whereas in one-third of
cases, the clinical signiﬁcance of this ﬁnding was doubtful. It was concluded that growth of Clostridium
spp. in blood cultures, even in the absence of one of the histotoxic syndromes, is often of clinical
signiﬁcance, and that such ﬁndings should be properly evaluated and not ignored.
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INTRODUCTION
Historically,Clostridium spp. bacteraemia has been
associated with severe, rapidly fatal, histotoxic
syndromes, including cellulitis, fasciitis, myonec-
rosis (gas gangrene) and fulminant intravascular
haemolysis. Nowadays, these classic syndromes
are seen rarely, but up to 3% of all blood cultures in
hospitalised patients still yield Clostridium spp. [1].
The discrepancy between the classic, rapidly fatal
clostridial disease and the relatively benign clinical
syndromes associated with clostridial bacteraemia
described in the modern literature has prompted
clinicians to examine the signiﬁcance of the growth
of Clostridium spp. in blood cultures [2–7]. Follow-
ing several studies of groups of patients with
benign clostridial bacteraemia, it was concluded
that growth ofClostridium spp. from blood cultures
often represented contamination or transient bac-
teraemia of little or no clinical signiﬁcance [1–5,7].
A clear-cut clinical relevance was found in a
minority of conditions [1]. However, interpretation
was always subjective, and no published study has
included a comparator group to evaluate the
signiﬁcance of Clostridium bacteraemia.
The purpose of the present studywas to examine
the signiﬁcance of Clostridium bacteraemia by two
methods: (1) by comparing patients with Clostrid-
ium bacteraemia with a group of patients with
Bacillus spp. isolated from blood culture, and
making the assumption that isolation of Bacillus
spp. from blood culture almost invariably repre-
sents contamination; and (2) by individually eval-
uating each case of Clostridium bacteraemia for its
clinical relevance and the possible source of infec-
tion.
PATIENTS AND METHODS
Setting
The Tel Aviv Sourasky Medical Center is a 1150-bed university
hospital serving a mostly elderly population. As a part of an
ongoing prospective surveillance of positive blood cultures, all
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caseswithbloodcultures yieldingClostridium spp. between1997
and2000 (4 years, 81patients)were re-evaluated for thepurpose
of this study. In addition, the details of 100 cases in which
Bacillus spp.were grown fromblood culturewere collected from
the microbiology laboratory computer, starting from January
1997 and compiling the ﬁrst 100 evaluable cases (until August
1999), excluding those with insufﬁcient information or unavail-
able or incomplete records.Medical recordswere reviewed, and
relevant demographical, bacteriological and clinical data were
collected, including diagnoses on the day of bacteraemia and
discharge diagnoses. No clinical information could be retrieved
for one case of Clostridium bacteraemia, and this case was
excluded from the study.
Study protocol
The ﬁrst part of the study consisted of a comparison between
the 80 Clostridium and the 100 Bacillus cases. In this part of the
study, all case histories were reviewed and all cases were
analysed in the same way, without judging whether the blood
culture results represented clinically signiﬁcant or non-signi-
ﬁcant bacteraemia. At the time blood culture results were
reported, the vast majority of the Clostridium cases and all of
the Bacillus cases were considered to represent contamination,
including two patients with Bacillus growing from two blood
culture specimens each, but without any indication of a
clinically signiﬁcant ﬁnding.
The second part of the study consisted of an in-depth
analysis of the 80 Clostridium cases by a clinician expert in
infectious diseases, taking into consideration all pertinent
clinical data. For each case, the most likely focus or source of
infection was determined and the signiﬁcance of the positive
blood culture was assessed. In this analysis, Clostridium cases
were categorised into two groups: those that most likely
represented clinically signiﬁcant bacteraemia, and those of
unknown clinical signiﬁcance (including putative contamin-
ation). The categorisation of a case as most likely representing
clinically signiﬁcant bacteraemia was based on the presence
of at least one of the following: a focus or a source of infection
appropriate for possible involvement of Clostridium (e.g.,
acute cholecystitis, faecal peritonitis or decubitus ulcer);
clinical presentation of severe sepsis in the absence of an
evident focus of infection making Clostridium infection
unlikely (e.g., urosepsis with Escherichia coli growing from
blood and urine); and more than one blood culture specimen
that grew Clostridium.
Bacteriological methods
Blood cultures were taken at the discretion of the responsible
physicians and were inoculated into BacT ⁄Alert bottles (bio-
Me´rieux, Durham, NC, USA). Identiﬁcation of isolates was by
standard bacteriological methods with the use of an automated
MicroScan system (Baxter Healthcare, Deerﬁeld, IL, USA) in
accordance with NCCLS guidelines.
Statistics
Continuous variables (e.g., age) were compared using Stu-
dent’s t-test. Categorical variables were compared using the
chi-square test, with Yates’ correction, or two-tailed Fisher’s
exact test where applicable. Results were considered signiﬁ-
cant when p was < 0.05.
Deﬁnitions
Blood culture specimen. Either one bottle or a set of two bottles
(aerobic and anaerobic) obtained by a single venipuncture.
Community-acquired infection. Blood cultures were obtained
within 48 h of admission, the patient had not been discharged
from a hospital within the preceding week, and the bacterae-
mia was not related to a procedure performed in the hospital.
Hospital-acquired infection. When the ﬁrst sign of infection
appeared > 48 h following admission, or the infection was
related to an in-hospital procedure, even in the ﬁrst 48 h, or the
patient had been hospitalised within the previous week.
Nursing home-acquired infection. The patient was admitted from
a nursing home.
Polymicrobial infection. Blood cultures yielding microorganisms
other than Clostridium ⁄Bacillus, obtained on the day of bacter-
aemia or within ± 3 days, and judged to be related to the same
clinical episode.
Mortality, overall. All deaths within the same admission.
Mortality, early. Death within 8 days of the bacteraemia.
Septic shock, severe sepsis, sepsis, bacteraemia. According to the
deﬁnitions of the American College of Chest Physicians ⁄ Soci-
ety of Critical Care Medicine Consensus Conference Commit-
tee [8].
RESULTS
This study included 80 episodes of Clostridium
bacteraemia in 80 patients, with 81 isolates of
Clostridium spp., during a 4-year study period
(1997–2000). The 79 episodes in adults (one was in
a neonate) constituted 1.7% of the 4592 bacterae-
mic episodes recorded in adults during the 4-year
study period.
The ﬁrst part of the study compared the 80
cases of Clostridium spp. bacteraemia with 100
cases of Bacillus bacteraemia. There were some
signiﬁcant differences in the demographical,
epidemiological and clinical features of the two
groups (Table 1). The mean age of the Bacillus
group was signiﬁcantly lower than that of the
Clostridium group, mainly because of the pres-
ence of more children. Also, being homeless or
having a solid tumour (especially colon cancer)
as the underlying condition were both more
prevalent in the Clostridium group. Although the
number of episodes with more than one positive
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blood culture specimen, and being a nursing
home resident, were more prevalent in the
Clostridium group, these differences did not
reach statistical signiﬁcance. Total, as well as
early, mortality rates were higher in the Clostrid-
ium group, but the difference in early mortality
did not reach statistical signiﬁcance.
The main clinical diagnoses on the day of
bacteraemia involved gastrointestinal infection
much more frequently in the Clostridium group
than in the Bacillus group (27 vs. 8%, p 0.001;
Table 1). Faecal peritonitis, biliary tract infection
and post-partum fever were present solely in the
Clostridium group. In contrast, respiratory tract
infection was a more common diagnosis among
the Bacillus cases.
A striking difference was observed regarding
polymicrobial bacteraemia. In the Clostridium
group, 33 additional microorganisms were
isolated from blood in 29 episodes, compared
with only 12 organisms in ten episodes in the
Bacillus group (Table 1). Furthermore, there
was no statistical difference between the two
groups in terms of the frequency of addi-
tional microorganisms considered to be con-
taminants, whereas true additional pathogens
were much more common in the Clostridium
group.
Table 1. Comparison of demogra-
phical, epidemiological and clinical
features of patients with Clostridium
vs. Bacillus bacteraemia
Clostridium
n (%)
Bacillus
n (%)
p
Total patients 80 (100) 100 (100)
Patients with > 1 positive blood culture specimen 7 (9)a 2 (2) 0.08
Male gender 47 (59) 49 (49) NS
Age in years, mean ± SD 70 ± 20 65 ± 25 < 0.001
Patients aged £ 10 years 1 (1) 6 (6) NS
Fever > 38C at the time of bacteraemia 53 (66) 73 (73) NS
Hypothermia at the time of bacteraemia 4 (5) 1 (1) NS
Place and circumstances of acquisition
Community-acquired from home 41 (51) 63 (63) NS
Community-acquired from nursing home 7 (9) 2 (2) 0.08
Community-acquired among homeless individuals 7 (9) 1 (1) 0.02
Hospital-acquired 25 (31) 34 (34) NS
Co-morbidities
Diabetes mellitus 15 (19) 26 (26) NS
Alcoholism 10 (12) 6 (6) NS
Chronic lung disease 7 (9) 17 (17) NS
Chronic renal failure 6 (7) 8 (8) NS
Neoplastic disease 25 (31) 26 (26) NS
Haematological malignancy 4 (5) 14 (14) 0.08
Solid tumours 21 (26) 12 (12) 0.02
Colorectal carcinoma 7 (9) 2 (2) 0.08
Chemotherapy within last month 6 (7) 6 (6) NS
None of the above co-morbidities 20 (25) 30 (30) NS
Mortality
Very early (within 2 days of bacteraemia) 10 (12) 4 (4) 0.07
Early (within 3–8 days of bacteraemia) 6 (7) 7 (7) NS
Total (very early + early + late) 23 (28) 15 (15) 0.04
Main diagnosis on the day of positive blood cultures
Gastrointestinal infection 22 (27) 8 (8) 0.001
Urinary tract infection 18 (22) 16 (16) NS
Respiratory tract infection 11 (14) 28 (28) 0.03
Skin and soft-tissue infection 6 (7) 7 (7) NS
Neutropenic fever 4 (5)b 7 (7) NS
Post-procedure fever 2 (2)c 3 (3)d NS
Self-resolving fever with no speciﬁc diagnosis 4 (5) 12 (12) NS
Severe sepsis without an evident source 6 (7) 5 (5) NS
Other infectious diagnoses 3 (4)e 4 (4)f NS
Other non-infectious diagnoses 4 (5)g 10 (10)h NS
Antibiotic therapy not administered 6 (7) 19 (19) 0.04
Polymicrobial bacteraemia
No. of patients 29 (36) 10 (10) < 0.0001
No. of isolates considered to be
contaminants (CNS and corynebacteria only)
13 (16) 8 (8) NS
No. of true pathogens, excluding contaminants 20 (25) 4 (4) < 0.0001
aAll seven were Clostridium perfringens.
bTwo of the four were Clostridium septicum.
cPost-partum (2).
dPost-angiography, colectomy and orthopaedic surgery.
eNeonatal fever, Mycobacterium avium-intracellulare infection in AIDS, fever and leukocytosis with no identiﬁed
source of infection.
fLymphangitis, ovarian abscess, varicella and unspeciﬁed viral infection.
gPulmonary oedema, chemical cellulitis, hyponatraemia and stroke.
hIntra-cerebral haemorrhage (3), arthritis (2), pulmonary oedema (2), drug fever (2), and alcohol intoxication.
CNS, coagulase-negative staphylococci.
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In the second part of the study, patients with
Clostridium bacteraemia were re-categorised by an
infectious diseases expert (Table 2). This analysis
showed that 54 (67.5%) of the patients with
Clostridium bacteraemia probably had a clinically
signiﬁcant bacteraemia, whereas 26 (32.5%) epi-
sodes were considered to represent contamination
or non-signiﬁcant bacteraemia (Table 2). The dis-
crepancy between the lists of diagnoses in Table 1
and Table 2 is explained by the differences
between diagnoses written in the medical records
and the interpretation by the infectious diseases
expert. For example, many patients designated by
the ward staff as having urinary tract infection
had negative urine cultures. Some of these
patients had severe decubitus ulcers, and were
therefore re-categorised as having a soft-tissue
source of a clinically signiﬁcant Clostridium bac-
teraemia. Other patients were re-categorised as
having severe sepsis of unknown origin. Patients
with neutropenic fever, according to the written
records, were placed in the appropriate sub-
groups according to the identiﬁed or unknown
source of infection, etc.
Not surprisingly, mortality in the clinically
signiﬁcant bacteraemia group was very high; 18
(33%) of 54 patients died during hospitalisation,
but, by deﬁnition, severe sepsis was categorised
as clinically signiﬁcant bacteraemia. Interestingly,
almost all patients with mixed growth from blood
belonged to the group of clinically signiﬁcant
Clostridium bacteraemias, except for the small
group with bacteraemic urinary tract infection,
where the E. coli in blood was considered to be the
only signiﬁcant pathogen and the Clostridium sp.
was regarded as a contaminant.
The most common clostridial species was
Clostridium perfringens, found in 71% of cases
(Table 3). There was no signiﬁcant difference in
the distribution of species between the signiﬁcant
Table 2. Clinical categories, diagno-
ses and outcome in patients with
Clostridium bacteraemia, as inter-
preted by an infectious diseases
expert
Clinical condition
No. of
patients
Mortality,
earlya (+ late)
Additional organisms
in blood, PMB
Clinically signiﬁcant
Clostridium sepsis ⁄ bacteraemia
Severe sepsis ⁄ septic shock 32 14 (+ 4)
Peritonitis 3 Escherichia coli,
Fusobacterium nucleatum
Abscess 2 CNS
Cholangitis ⁄ cholecystitis 4 E. coli,
Eubacterium lentum
Acute megacolon 1
Severe abdominal pain 4 Streptococcus bovis
Surgical wound infection 1
Decubitus ulcers 6 Proteus penneri,
Eubacterium limosum,
Pseudomonas aeruginosa,
S. bovis,
Staphylococcus simulans,
Staphylococcus schleiferi
Leg sores 1 CNS
Unknown source 10 7 (+ 1) Proteus vulgaris,
Staphylococcus aureus,
Enterobacter spp.,
Eubacterium lentum,
CNS
Sepsis ⁄ bacteraemia 22
Colitis ⁄ gastroenteritis 9 CNS
Diverticulitis 1 Corynebacterium spp.
GI bleed ⁄ abdominal pain 2 CNS
Skin injuries ⁄wounds 5
Post-procedure 5b CNS
Clostridium bacteraemia
of unknown clinical signiﬁcance
Alternative clinical diagnosis 26 2 (+ 3)
Urosepsis 4 1 (+ 1) E. coli (4)
Non-bacteraemic UTI 5 1 CNS (2)
Pneumonia 5 (+ 1) Clostridium septicum
Bronchitis 3 CNS
HIV and MAI infection 1 Corynebacterium spp.
Fever of undetermined cause 4 (+ 1) E. coli, S. bovis
Non-infectious diagnoses 4c
aEarly mortality, within 8 days of bacteraemia.
bPost-partum (2), neonatal fever, post-colonoscopy and post-colectomy.
cPulmonary oedema, chemical cellulitis, hyponatraemia, and stroke.
CNS, coagulase-negative Staphylococcus; HIV, human immunodeﬁciency virus; MAI, Mycobacterium avium-
intracellulare; PMB, polymicrobial bacteraemia; UTI, urinary tract infection; GI, gastrointestinal.
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and non-signiﬁcant bacteraemia groups, and
there was no difference in the species-speciﬁc
mortality rate (Table 3). Two of the four Clostrid-
ium septicum isolates were associated with two of
the four cases of neutropenic fever.
DISCUSSION
Clostridia are widespread in nature and are found
primarily in soil and the intestinal tract of humans
and animals. They are well-known for their ability
to cause serious and fatal diseases, the so-called
histotoxic syndromes, the most fulminant of
which is gas gangrene. Early studies (before
1960) consisted mostly of clinical and microbiolo-
gical observations of the serious and fulminant
nature of clostridial infections. Ramsay [3] was
probably the ﬁrst (in 1949) to describe benign
clinical courses in 17 of 28 bacteraemic post-par-
tum and post-abortum women, with what was
then called Clostridium welchii in blood, and
concluded that Clostridium in blood may be
‘saprophytic or associated with mild infections’.
Most subsequent studies were conducted be-
fore the 1990s, and very few data have appeared
in more recent years. Although published studies
differ signiﬁcantly in terms of the population
studied, the species of Clostridium included, and
the extent of the clinical information supplied,
some common general conclusions can be
reached: (1) Clostridium bacteraemia is uncom-
mon, constituting 0.7–2.6% (1.7% in the present
study) of all bacteraemic episodes in the studies
that supplied this information [2,6,9–11]; (2) the
vast majority of cases do not have the character-
istics of the classic histotoxic syndromes; (3)
C. perfringens is the most common species in-
volved; (4) Clostridium bacteraemia is associated
with high in-hospital mortality, varying between
15% and 86%, but mostly > 40%; (5) Clostridium
bacteraemia is associated frequently with malig-
nant disease, primarily acute leukaemia and
carcinoma of the colon; (6) the common sources
(and foci) of Clostridium bacteraemia are the
gastrointestinal tract (including biliary tract infec-
tion), soft-tissue infection and female genital tract
manipulation; (7) polymicrobial infection is very
common, ranging between 6% and 83%, but
mostly c. 40–50%; and (8) the interpretations and
conclusions concerning the clinical signiﬁcance of
Clostridium in blood vary widely. Two studies
included only C. septicum bacteraemia, and all of
the included patients were overwhelmingly ill
[12,13]. Other studies that included various spore-
forming, as well as non-spore-forming, clostridia
demonstrated mostly severe disease and did not
even consider the possibility of contamination
[6,9,11,14]. Some studies assumed that all cases
represented clinically signiﬁcant bacteraemia,
even though no source of infection could be
identiﬁed in the majority of cases [5,7], and many
studies suggested that Clostridium bacteraemia
may often be transient or of no clinical signiﬁ-
cance [2,4,10,15–17]. Some investigators have
reported that appropriate antimicrobial therapy
for Clostridium did not affect clinical outcome
signiﬁcantly, and used this as an argument that
Clostridium spp. are not signiﬁcant in blood
cultures [7,17,18].
Since none of these studies used a comparator
group to enable a more evidence-based conclu-
sion, the present study compared a group of
patients with Clostridium bacteraemia with a
group of patients who had positive blood cultures
for Bacillus spp., which are generally considered
to be contaminants [19,20]. The assumption was
that patients with Bacillus in blood cultures
represented the overall population from whom
blood cultures are drawn, but that the ﬁnding of
Bacillus spp. represents contamination. If Clostrid-
ium spp. were also mostly a result of contamin-
ation, the two groups should have been similar.
Table 3. Species distribution of 81
isolates of Clostridium spp. from
blood cultures in 80 clinical epi-
sodesa, grouped according to clinical
signiﬁcance and species-
speciﬁc mortality
Species
No. of
isolates
Severe sepsis
⁄ septic shock
Sepsis
⁄ bacteraemia
Unknown
signiﬁcance
Early mortality
(£ 8 days)
C. perfringens 57 (71%) 22 (69%) 15 (68%) 20 (74%) 13 (23%)
C. ramosum 9 (11%) 2 (6%) 3 (14%) 4 (15%) –
C. septicum 4 (5%) 2 (6%) 1 (5%) 1 (4%) 1 (25%)
C. clostridiiforme 2 (2%) 1 (3%) – 1 (4%) 1 (50%)
C. bifermentans 1 (1%) 1 (3%) – – –
C. cadaveris 1 (1%) 1 (3%) – – –
C. sordellii 1 (1%) – 1 (5%) – –
C. tertium 1 (1%) 1 (3%) – – –
Other Clostridium spp. 5 (6%) 2 (6%) 2 (9%) 1 (4%) 1 (20%)
Total 81 (100%) 32 (100%) 22 (100%) 27 (100%) 16 (20%)
aOne culture yielded both C. ramosum and C. septicum from the same specimen.
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However, the comparison identiﬁed some clear
dissimilarities, which suggested that cases with
Clostridium bacteraemia, as a group, behaved
differently from the group with contaminated
blood cultures. Clostridium bacteraemia patients
were older, were more seriously ill (fewer cases of
self-limited disease and more frequent use of
antibiotics), included more homeless people (as
well as alcoholics, but the case numbers were too
low to attain signiﬁcance), and had a higher
frequency of gastrointestinal diseases, especially
colorectal tumours, than the general hospital
population from whom blood cultures are drawn.
The association of Clostridium growth and home-
lessness could be ascribed to a higher likelihood
of contamination; however, of seven homeless
people with Clostridium in their blood, four had
infected skin lesions, two had abdominal pain,
and in only one case (a patient with pyelonephri-
tis and E. coli in blood) was the Clostridium
considered to be a contaminant. In addition,
Clostridium spp. were involved frequently in cases
of polymicrobial bacteraemia with a higher mor-
tality rate. The total mortality rate of 33% (18 ⁄ 54)
found in the clinically signiﬁcant cases of Clos-
tridium bacteraemia was identical to the overall
mortality documented among bacteraemic
patients in the same institution [21]. The larger
number of patients with respiratory infection in
the Bacillus group probably represents the fre-
quency of pneumonia among patients for whom
blood cultures fail to reveal the pathogen. Also,
the mortality rate of 15% in the Bacillus group
probably represents the mortality rate among
patients for whom blood cultures are taken that
remain negative. This number falls between the
overall mortality rate in hospitalised adults in this
institution (c. 4%) and the mortality rate in
bacteraemic adults (32%) [21].
The individual evaluation of patients with Clos-
tridium spp. in blood cultures suggested that at
least two-thirds of these patients had clinically
signiﬁcant bacteraemia. These patients could be
divided further into 32 (40%) patients with severe
sepsis and septic shock who had a high rate of
polymicrobial infection (13 additional pathogenic
microorganisms) and exceptionally high mortality
(18 of 32; 56%), and 22 (27.5%) patientswith benign
bacteraemia, nomortality and no additional patho-
genic microorganisms. In the other 26 (32.5%)
patients, no deﬁnite clinical signiﬁcance could be
ascribed to the ﬁnding of Clostridium spp. in blood.
In summary, Clostridium spp. isolated from
blood cultures represents true infection more
often than not. Therefore, each patient with
positive blood cultures for Clostridium spp. should
be evaluated in the same way as any patient with
bacteraemia, including a search for a source or
focus of infection, with special attention to
possible soft-tissue infection, gastrointestinal
pathology, biliary tract disease, or possible female
genital tract involvement. Documentation of Clos-
tridium bacteraemia should not be discarded as
non-signiﬁcant unless a thorough evaluation fails
to reveal any clinical relevance.
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